Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HAVN Life Sciences Inc HAVLF


Primary Symbol: C.HAVN

HAVN Life Sciences Inc. is a Canada-based biotechnology company. The Company is engaged in the scientific research and development of psychopharmacological and natural health care products. It is focused on standardizing extraction of psychoactive compounds, the development of natural health products, and developing mental health treatments to support brain health and enhance the capabilities... see more

Recent & Breaking News (CSE:HAVN)

HAVN Life Harvests First Crop of Psilocybin Mushrooms at its Jamaica Facility

Accesswire August 3, 2021

HAVN Life Natural Health Products Now Available on Amazon.ca

Accesswire July 29, 2021

HAVN Life Signs Agreement to Enable Export of Psilocybin into Canada, the US and Europe

Accesswire July 27, 2021

HAVN Life Signs Exclusive Supply Agreement With Cube Psytech

Accesswire July 8, 2021

Allied Corp and HAVN Life Sciences (CSE:HAVN) sign psilocybin manufacturing agreement

Trevor Abes  June 29, 2021

Allied Corp Signs Psilocybin Manufacturing Agreement To Produce Psilonex(TM) RX For What We Believe To Be The Largest Known Psilocybin Patient Cohort In The World

GlobeNewswire June 29, 2021

HAVN Life Sciences Signs Finished Goods Supply Agreement with Allied Health

Accesswire June 29, 2021

HAVN Life Announces Retail Partnership with Grocer, Choices Markets

Accesswire June 8, 2021

HAVN Life Launches New Line of Natural Health Products

Canada NewsWire June 3, 2021

HAVN Life Completes Acquisition of Clinical Stage IP for Development of Cluster Headache Drug

Accesswire June 2, 2021

Lobe Sciences (CSE:LOBE) secures production and supply agreement for Vitamind natural health products

Julia Kennedy  May 19, 2021

HAVN Life Secures Production & Supply Agreement to Expand Retail Product Offerings

Accesswire May 19, 2021

HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches

Accesswire May 17, 2021

Havn Life CEO Tim Moore to Appear at Upcoming Q2 Investor SummitHavn Life CEO Tim Moore to Appear at Upcoming Q2 Investor Summit

Accesswire May 14, 2021

Havn Life Signs Exclusive Supply Agreement with ATMA Journey Centers

Accesswire May 13, 2021

Havn Life Develops New Method for Rapid Psilocybin Testing

Accesswire May 11, 2021

Top Mushroom Stocks Sprouting on the Health and Witness Trend

Press Releases May 4, 2021

Havn Labs Jamaica Facility Now Fully Operational

Accesswire May 4, 2021

Psychedelics Could be Your Next Multi-Billion-Dollar Opportunity

Press Releases April 20, 2021

Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021

Accesswire April 19, 2021